TTD | Drug: D0ZG3Q

Drug General Information
Drug ID	D0ZG3Q
Former ID	DNC007775
Drug Name	2-(adamantan-1-ylamino)-5,5-diethyl-oxazol-4-one
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[528929]
Structure		Download 2D MOL 3D MOL
Formula	C17H26N2O2
Canonical SMILES	CCC1(C(=O)N=C(O1)NC23CC4CC(C2)CC(C4)C3)CC
InChI	1S/C17H26N2O2/c1-3-17(4-2)14(20)18-15(21-17)19-16-8-11-5-12(9-16)7-13(6-11)10-16/h11-13H,3-10H2,1-2H3,(H,18,19,20)
InChIKey	RHBIZJSBQCBDJJ-UHFFFAOYSA-N
PubChem Compound ID	44433328
Target and Pathway
Target(s)	Corticosteroid 11-beta-dehydrogenase, isozyme 1	Target Info	Inhibitor	[528929]
KEGG Pathway	Steroid hormone biosynthesis
	Metabolism of xenobiotics by cytochrome P450
	Metabolic pathways
	Chemical carcinogenesis
NetPath Pathway	IL1 Signaling Pathway
NetPath Pathway	FSH Signaling Pathway
PathWhiz Pathway	Steroidogenesis
Reactome	Glucocorticoid biosynthesis
WikiPathways	Prostaglandin Synthesis and Regulation
	Metabolism of steroid hormones and vitamin D
	Glucocorticoid & Mineralcorticoid Metabolism
References
Ref 528929	Bioorg Med Chem Lett. 2007 Sep 1;17(17):4837-40. Epub 2007 Jun 20.Oxazolones as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.
Ref 528929	Bioorg Med Chem Lett. 2007 Sep 1;17(17):4837-40. Epub 2007 Jun 20.Oxazolones as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information